Literature DB >> 18521370

Analysis of lung metastases in patients with primary extremity sarcoma.

N Songür1, M Dinç, C Ozdilekcan, S Eke, U Ok, M Oz.   

Abstract

PURPOSE: To investigate the incidence, radiographic findings, and the time course for the appearence of lung metastases from primary extremity sarcoma. PATIENTS AND METHODS: Four-hundred patients with extremity sarcoma were evaluated retrospectively for lung metastases. Multiple clinical factors were analyzed for possible influence on the metastases-free interval and subsequent metastases development. Radiographic findings of metastases were also reviewed.
RESULTS: Ninety of 400 patients (23%) developed lung metastases. Median time from presentation to detection of metastasis was 8.0 +/- 1.1 months (95% CI: 6.02-9.98). More than 75% of patients developed metastases within 1 year after presentation of the primary sarcoma. As disease grade increased, the metastases-free intervals shortened significantly. Histologically, synoviosarcoma and osteogenic sarcoma were more often associated with the development of lung metastases. In this subgroup, 54 patients (60%), the presence of solitary (11) or multiple (43) nodular metastases was the only radiological finding. In 36 of 90 patients (40%), parenchymal mass, pleural effusion, hilar lymphadenopathy and pneumothorax were found.
CONCLUSIONS: Twenty-three percent of patients in our study developed lung metastases. As the grade of the disease increased, metastases-free intervals are shortened. Although it has been reported that lung metastases in patients with extremity sarcomas may present as solitary or multiple nodules in earlier trials with radiographic screening methods, the current review of 400 patients found that a substantial number of patients may present radiological appearances other than nodular formations.

Entities:  

Year:  2003        PMID: 18521370      PMCID: PMC2395516          DOI: 10.1080/13577140310001607284

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  12 in total

1.  Multifactorial analysis of survival in primary extremity liposarcoma.

Authors:  H R Chang; J Gaynor; C Tan; S I Hajdu; M F Brennan
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  The problem of local recurrence after treatment of soft tissue sarcoma.

Authors:  J Cantin; G P McNeer; F C Chu; R J Booher
Journal:  Ann Surg       Date:  1968-07       Impact factor: 12.969

3.  Metastatic patterns in soft-tissue sarcomas.

Authors:  M P Vezeridis; R Moore; C P Karakousis
Journal:  Arch Surg       Date:  1983-08

4.  The problem of benign pulmonary nodules in children receiving cytotoxic chemotherapy.

Authors:  H Hidalgo; M Korobkin; T R Kinney; J Falletta; D H Heaston; D R Kirks
Journal:  AJR Am J Roentgenol       Date:  1983-01       Impact factor: 3.959

5.  Pulmonary metastatic disease: radiologic-surgical correlation.

Authors:  M Peuchot; H I Libshitz
Journal:  Radiology       Date:  1987-09       Impact factor: 11.105

6.  Patterns of recurrence in patients with high-grade soft-tissue sarcomas.

Authors:  D A Potter; J Glenn; T Kinsella; E Glatstein; E E Lack; C Restrepo; D E White; C A Seipp; R Wesley; S A Rosenberg
Journal:  J Clin Oncol       Date:  1985-03       Impact factor: 44.544

Review 7.  Management of extremity soft-tissue sarcoma.

Authors:  M F Brennan
Journal:  Am J Surg       Date:  1989-07       Impact factor: 2.565

Review 8.  Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma.

Authors:  M A Gadd; E S Casper; J M Woodruff; P M McCormack; M F Brennan
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

9.  Lung resection for metastatic sarcoma.

Authors:  M N Huang; F Edgerton; H Takita; H O Douglas; C Karakousis
Journal:  Am J Surg       Date:  1978-06       Impact factor: 2.565

10.  A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors.

Authors:  G Markhede; L Angervall; B Stener
Journal:  Cancer       Date:  1982-04-15       Impact factor: 6.860

View more
  8 in total

1.  The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells.

Authors:  Vladimír Cermák; Jan Kosla; Jirí Plachý; Katerina Trejbalová; Jirí Hejnar; Michal Dvorák
Journal:  Cell Mol Life Sci       Date:  2010-05-28       Impact factor: 9.261

2.  Strain-specific susceptibility for pulmonary metastasis of sarcoma 180 cells in inbred mice.

Authors:  Haris G Vikis; Erin N Jackson; Alexander S Krupnick; Andrew Franklin; Andrew E Gelman; Qiong Chen; David Piwnica-Worms; Ming You
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

3.  Spontaneous bilateral pneumothorax in a patient with metastatic synovial sarcoma while under chemotherapy.

Authors:  Mohammed Sadeq Ahmed
Journal:  Transl Lung Cancer Res       Date:  2012-12

4.  What Is the Clinical Importance of Incidental Findings on Staging CT Scans in Patients With Sarcoma?

Authors:  Zachary Mayo; Sean Kennedy; Yubo Gao; Benjamin J Miller
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

5.  The influence of pulmonary metastasectomy on survival in osteosarcoma and soft-tissue sarcomas: a retrospective analysis of survival outcomes, hospitalizations and requirements of home oxygen therapy.

Authors:  Samer Salah; Said Fayoumi; Abdellatif Alibraheem; Ehab Massad; Riad Abdel Jalil; Sameer Yaser; Faisal Albadainah; Hamzeh Albaba; Mohammad Maakoseh
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-04-18

6.  CT scans for pulmonary surveillance may be overused in lower-grade sarcoma.

Authors:  Benjamin J Miller; Emily E Carmody Soni; John D Reith; C Parker Gibbs; Mark T Scarborough
Journal:  Iowa Orthop J       Date:  2012

7.  Willingness of patients with sarcoma to participate in cancer surveillance research: a cross-sectional patient survey.

Authors:  Patricia Schneider; Victoria Giglio; Dana Ghanem; David Wilson; Robert Turcotte; Marc Isler; Sophie Mottard; Benjamin Miller; James Hayden; Yee-Cheen Doung; Kenneth Gundle; R Lor Randall; Kevin Jones; Roberto Vélez; Michelle Ghert
Journal:  BMJ Open       Date:  2021-02-26       Impact factor: 2.692

8.  The Surveillance After Extremity Tumor Surgery (SAFETY) trial: protocol for a pilot study to determine the feasibility of a multi-centre randomised controlled trial.

Authors: 
Journal:  BMJ Open       Date:  2019-09-18       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.